A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension.
Phase of Trial: Phase III
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Losartan (Primary) ; Losartan (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 15 Mar 2013 New source identified and integrated (Clinical Trials Registry - India; CTRI2009-091-000045).
- 01 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.